FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer

Background: Venous thromboembolism (VTE) occurs when blood clots in the leg, pelvic or other deep vein (deep vein thrombosis) with or without transport of the thrombus into the pulmonary arterial circulation (pulmonary embolus). VTE...

Full description

Bibliographic Details
Main Authors:	Griffiths, G, Burns, S, Noble, S, Macbeth, F, Cohen, D, Maughan, T
Format:	Journal article
Language:	English
Published:	BioMed Central 2009

Similar Items

Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer
by: Macbeth, F, et al.
Published: (2009)

FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer
by: Macbeth Fergus R, et al.
Published: (2009-10-01)

Fragmin v onkologii
by: V V Ptushkin
Published: (2004-12-01)

Gelsolin-Like Domain 3 Plays Vital Roles in Regulating the Activities of the Lily Villin/Gelsolin/Fragmin Superfamily.
by: Dong Qian, et al.
Published: (2015-01-01)

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer
by: Crosby, T, et al.
Published: (2017)

Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS)
by: Sébastien Thureau, et al.
Published: (2021-02-01)

SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus
by: Staffurth John N, et al.
Published: (2011-10-01)

Selection criteria for early breast cancer patients in the DBCG proton trial – The randomised phase III trial strategy
by: Line Bjerregaard Stick, et al.
Published: (2021-03-01)

The smoking cessation in pregnancy incentives trial (CPIT): study protocol for a phase III randomised controlled trial
by: Lesley Sinclair, et al.
Published: (2020-02-01)

Reporting of PPI and the MCID in phase III/IV randomised controlled trials—a systematic review
by: Joseph Brennan, et al.
Published: (2023-05-01)

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial.
by: Crosby, T, et al.
Published: (2013)

A Very Early Rehabilitation Trial after stroke (AVERT): a Phase III, multicentre, randomised controlled trial
by: Peter Langhorne, et al.
Published: (2017-09-01)

Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial
by: Msika Simon, et al.
Published: (2011-07-01)

A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol
by: Pascoe, S, et al.
Published: (2016)

Tenecteplase versus alteplase for acute ischaemic stroke: a meta-analysis of phase III randomised trials
by: Yongjun Wang, et al.

A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan and Ciclosporin in COLOrectal cancer therapy trial (PICCOLO).
by: Middleton, G, et al.
Published: (2013)

A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan and Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)
by: Middleton, G, et al.
Published: (2013)

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: the phase 1/randomised phase 2 SCALOP-2 trial
by: Mukherjee, S, et al.
Published: (2024)

Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III): a randomised, phase III, open-label, controlled trial
by: Bruce C V Campbell, et al.

Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer
by: Hurt, C, et al.
Published: (2017)

Fragility index of positive phase II and III randomised clinical trials of treatments for hepatocellular carcinoma (2002–2022)
by: Sabrina Sidali, et al.
Published: (2023-07-01)

Whole-body hypothermia in mild neonatal encephalopathy: protocol for a multicentre phase III randomised controlled trial
by: Garegrat, R, et al.
Published: (2024)

Trends in participant race and sex reporting in lung cancer phase III clinical trials
by: Faaiq N. Aslam, et al.
Published: (2023-09-01)

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.
by: Mukherjee, S, et al.
Published: (2013)

CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial
by: Dean A. Fennell, et al.
Published: (2018-04-01)

Raltitrexed (Tomudex) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1).
by: Popov, I, et al.
Published: (2008)

OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial
by: Wechsler, M, et al.
Published: (2017)

Heartburn relief with bicarbonate-rich mineral water: results of the randomised, placebo-controlled phase-III trial STOMACH STILL
by: JOACHIM LABENZ, et al.
Published: (2023-11-01)

Efficacy and safety of iclepertin (BI 425809) in patients with schizophrenia: CONNEX, a Phase III randomised controlled trial programme
by: P. Falkai, et al.
Published: (2023-03-01)

Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma: Results of a Randomised Phase III Trial (METEOR)
by: Toni Choueiri
Published: (2015-11-01)

Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial
by: Forder Peta M, et al.
Published: (2011-04-01)

Lung Cancer Clinical Trials with a Seamless Phase II/III Design: Systematic Review
by: Dionysios Palermos, et al.
Published: (2022-12-01)

Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials
by: Dadasovich Ryan, et al.
Published: (2009-04-01)

INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG)
by: Lyn Ley Lam, et al.
Published: (2023-02-01)

Lung Ultrasound-Guided Fluid Management versus Standard Care in Surgical ICU Patients: A Randomised Controlled Trial
by: Daniel-Mihai Rusu, et al.
Published: (2021-08-01)

IntReALL SR 2010: An international randomised phase III study for the treatment of standard risk childhood relapsed acute lymphoblastic leukaemia
by: von Stackelberg, A, et al.
Published: (2017)

CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial.
by: Day, N, et al.
Published: (2014)

Novel approaches to improve the therapeutic index of head and neck radiotherapy: an analysis of data from the PARSPORT randomised phase III trial.
by: Buettner, F, et al.
Published: (2012)

Study protocol for a phase III randomised controlled trial of Sailuotong (SLT) for vascular dementia and Alzheimer’s disease with cerebrovascular disease
by: Diana Karamacoska, et al.
Published: (2023-01-01)

Study protocol for a phase III randomised controlled trial of Sailuotong (SLT) for vascular dementia and Alzheimer's disease with cerebrovascular disease.
by: Diana Karamacoska, et al.
Published: (2023-01-01)